The Army general in charge of getting COVID-19 vaccines across the United States apologized on Saturday for “miscommunication” with states over the number of doses to be delivered in the early stages of distribution.
"I failed. I'm adjusting. I am fixing and we will move forward from there," Gen. Gustave Perna told reporters in a telephone briefing.
Perna's remarks came a day after a second vaccine was added in the fight against COVID-19, which has killed more than 312,000 people in the U.S. Governors in more than a dozen states have said the federal government has told them that next week’s shipment of the Pfizer-BioNTech vaccine will be less than originally projected.
Perna acknowledged the criticism and accepted blame.
“I want to take personal responsibility for the miscommunication,” he said. “I know that’s not done much these days. But I am responsible. ... This is a Herculean effort and we are not perfect."
The general said he made mistakes by citing numbers of doses that he believed would be ready.
“I am the one who approved forecast sheets. I'm the one who approved allocations,” Perna said. “There is no problem with the process. There is no problem with the Pfizer vaccine. There is no problem with the Moderna vaccine.”
There’s a distinction between manufactured vaccine and doses that are ready to be released. The finished product must undergo “rigorous quality control and sterility tests,” which can take up to a month, the Department of Health and Human Services said.
The Food and Drug Administration then must receive a certificate of analysis 48 hours before the manufacturer ships a batch, the government said.
Perna said the government now is on track to get approximately 20 million doses to states by the first week of January, a combination of the newly approved Moderna vaccine and the Pfizer-BioNTech vaccine.
Perna said 2.9 million Pfizer-BioNTech doses have been delivered to states so far.
In Michigan, where the Pfizer vaccine is produced, Democratic Gov. Gretchen Whitmer on Friday accused the White House of “slow-walking the process.” Michigan is due 60,000 doses of the Pfizer-BioNTech vaccine in its second allotment, down from an anticipated 84,825.
“We have Michigan hospitals and nursing homes ready to administer this vaccine," she said.